Drugs / [carbonyl-^11C]GW842166
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00511524 | Jun → Jul 2007 | inflammatory disease | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [carbonyl-^11C]GW842166 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00511524 ↗ |
| Route | Intravenous | “Intravenous solution” NCT00511524 ↗ |